Jyothi Mann, MD
Gastroenterology · Greensboro, NCNPI 1881701928
Payments from drug & device makers
Across 594 payments — averaging $746.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironwood Pharmaceuticals, Inc$242K
- Eli Lilly$90K
- Bristol Myers Squibb$87K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$10K
- Takeda Pharmaceuticals U.S.A., Inc.$4K
- AbbVie$3K
- plus $8K from 26 others
Across 5 payments — averaging $4313.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$22K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironwood Pharmaceuticals, Inc | 48 | $242,013 |
| Eli Lilly | 4 | $90,107 |
| Bristol Myers Squibb | 26 | $86,999 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $9,700 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $3,948 |
| AbbVie(2 entities) | 171 | $3,002 |
| Adare Pharmaceuticals, Inc. | 1 | $2,019 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 86 | $1,288 |
| Johnson & Johnson | 53 | $1,105 |
| Pfizer | 41 | $656 |
| Ardelyx, Inc. | 27 | $543 |
| Ferring Pharmaceuticals Inc. | 21 | $315 |
| Lilly USA, LLC | 13 | $265 |
| Intercept Pharmaceuticals, Inc. | 12 | $253 |
| Gilead | 7 | $138 |
| Regeneron Healthcare Solutions, Inc. | 6 | $133 |
| Phathom Pharmaceuticals, Inc. | 6 | $132 |
| Nestle Healthcare Nutrition Inc. | 7 | $125 |
| Sanofi | 7 | $119 |
| Braintree Laboratories, Inc. | 5 | $99 |
| Fresenius Kabi USA, LLC | 4 | $79 |
| Merck | 4 | $79 |
| Madrigal Pharmaceuticals | 3 | $77 |
| Boehringer Ingelheim | 3 | $62 |
| Celltrion USA Inc. | 3 | $59 |
| Sandoz | 3 | $58 |
| Intra-sana Laboratories | 1 | $49 |
| QOL Medical, LLC | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Organon | 1 | $25 |
| Shire North American Group Inc | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $15 |
How this compares
$443,543 in reported general payments places this provider in the 90th percentile of 610 gastroenterology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Greensboro
- Evan DellonChapel Hill$11.2M
- Andrew MuirDurham$6.6M
- Manal AbdelmalekDurham$5.6M
- Robert ReindollarSalisbury$2.5M
- John PoulosFayetteville$2.1M
- Hans HerfarthChapel Hill$2M
- Herbert BonkovskyWinston Salem$1.7M
- Ikechukwu IbegbuJacksonville$1.5M
- Nicholas ShaheenChapel Hill$1.5M
- David LeimanDurham$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.